Brain-Derived Neurotropic Factor Serum Level and Severity Symptom of Bataknese Male Patients with Schizophrenia in North Sumatera, Indonesia

Authors

  • Deasy Hendriati Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Elemeida Effendy Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Mustafa Mahfud Amin Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Vita Camellia Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia
  • Muhammad Surya Husada Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan 20155, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2019.550

Keywords:

Schizophrenia, Brain-derived Neurothropic Factor, Severity Symptom, Bataknese

Abstract

BACKGROUND: Schizophrenia is a severe mental disorder that is multi-causative and multi-factor, generally affecting about 1% of the population. The elevation level of brain-derived neurotrophic factor (BDNF) offers several protections from other neurodegenerative processes that occur in schizophrenia since this deficit of neurotrophic factors can contribute to changes in brain structure and function that underlie the schizophrenia psychopathology.
AIM: To analyse the correlation between BDNF serum levels and symptom severity by using the Positive and Negative Syndrome Scale (PANSS) instrument in Bataknese male patients with schizophrenia
METHODS: This study was a correlative analytical study with a cross-sectional approach using the Positive and Negative Syndrome Scale (PANSS) instrument to assess symptom severity with 60 subjects of Bataknese male patients with chronic schizophrenia. Moreover, this research was conducted at the Psychiatric Hospital of Prof. Dr M. Ildrem Medan, Indonesia. BDNF serum was analysed with the Quantitative sandwich enzyme immunoassay technique by via Quantikine ELISA Human CXCL8/IL-8 HS. Also, the data analysis was performed through Spearman's correlative bivariate analytics using SPSS software.
RESULTS: A negative correlation between the BDNF serum level and the negative scale PANSS score in men with schizophrenia (r = -0.820, p < 0.001) was found. Moreover, there is a negative correlation between BDNF serum levels and PANSS total scores in men with schizophrenia (r = -0.648, p < 0.001)
CONCLUSION: BDNF serum level in Bataknese male patients with schizophrenia has a relationship that affects the severity of symptoms in schizophrenic patients, especially for negative symptoms.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.

Lewis DA, Lieberman JA. Catching up on schizophrenia: natural history and neurobiology. Neuron. 2000; 28:325-34. https://doi.org/10.1016/S0896-6273(00)00111-2

Frankle WG, Lerma J, Laruelle M. The synaptic hypothesis of schizophrenia. Neuron. 2003; 39:205-16. https://doi.org/10.1016/S0896-6273(03)00423-9

Heinz A, Romero B, Gallinat J, Juckel G, Weinberger DR. Molecular Brain Imaging and the Neurobiology and Genetics of Schizophrenia. Pharmacopsychiatry. 2003; 36:152-7. https://doi.org/10.1055/s-2003-45123 PMid:14677072

Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004; 363:2063-72. https://doi.org/10.1016/S0140-6736(04)16458-1

Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005; 10:40-68. https://doi.org/10.1038/sj.mp.4001558 PMid:15263907

Brown AS. Prenatal Infection as a Risk Factor for Schizophrenia. Schizophr Bull. 2006; 32:200-2. https://doi.org/10.1093/schbul/sbj052 PMid:16469941 PMCid:PMC2632220

Lang UE, Puls I, Müller DJ, Strutz-Seebohm N, Gallinat J. Molecular Mechanisms of Schizophrenia. Cell Physiol Biochem. 2007; 20:687-702. https://doi.org/10.1159/000110430 PMid:17982252

Kulhara P, Gupta S. What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis. Indian J Psychiatry. 2010; 52:21. https://doi.org/10.4103/0019-5545.58891 PMid:20174514 PMCid:PMC2824976

Koeva YA, Sivkov ST, Akabaliev VH, Ivanova RY, Deneva TI, Grozlekova LS, Georgieva V. Brain-derived neurotrophic factor and its serum levels in schizophrenic patients. Folia medica. 2014; 56(1):20-3. https://doi.org/10.2478/folmed-2014-0003 PMid:24812918

Zhang XY, Xiu MH, Chen DC, De Yang F, Wu GY, Lu L, et al. Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology (Berl). 2010; 212:301-7. https://doi.org/10.1007/s00213-010-1956-y PMid:20661552

Zhang XY, Chen D-C, Tan Y-L, Luo X, Zuo L, Lv M-H, et al. Smoking and BDNF Val66Met polymorphism in male schizophrenia: A case-control study. J Psychiatr Res. 2015; 60:49-55. https://doi.org/10.1016/j.jpsychires.2014.09.023 PMid:25455509

Binford SS, Hubbard EM, Flowers E, Miller BL, Leutwyler H. Serum BDNF Is Positively Associated With Negative Symptoms in Older Adults With Schizophrenia. Biol Res Nurs. 2018; 20:63-9. https://doi.org/10.1177/1099800417735634 PMid:29050493 PMCid:PMC5942501

Gourion D, Goldberger C, Leroy S, Bourdel M-C, Olié J-P, Krebs M-O. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport. 2005; 16:1407-10. https://doi.org/10.1097/01.wnr.0000175245.58708.6b PMid:16056149

Nurjono M, Lee J, Chong S-A. A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia. Clin Psychopharmacol Neurosci. 2012; 10:61-70. https://doi.org/10.9758/cpn.2012.10.2.61 PMid:23431036 PMCid:PMC3569148

Guillin O, Demily C, Thibaut F. Brainâ€Derived Neurotrophic Factor in Schizophrenia and Its Relation With Dopamine. Int Rev Neurobiol. 2007; 78:377-95. https://doi.org/10.1016/S0074-7742(06)78012-6

Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani M-R, Hosseini S-M-R, Yekehtaz H, et al. N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia. Clin Neuropharmacol. 2013; 36:185-92. https://doi.org/10.1097/WNF.0000000000000001 PMid:24201233

Heriawan R. Kewarganegaraan, Suku Bangsa, Agama dan bahasa sehari-hari Penduduk Indonesia. 1st ed. Jakarta: Badan Pusat Statistik; 2011.

Gottlieb J, Fan X, Goff DC. Rating Scales in Schizophrenia. Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. New York: Humana Press; 2010. https://doi.org/10.1007/978-1-59745-387-5_10

Akyol ES, Albayrak Y, Beyazyüz M, Aksoy N, Kuloglu M, Hashimoto K. Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome. Neuropsychiatr Dis Treat. 2015; 11:865-72. https://doi.org/10.2147/NDT.S79444 PMid:25848285 PMCid:PMC4386764

Libman-Sokołowska M, Drozdowicz E, Nasierowski T. BDNF as a biomarker in the course and treatment of schizophrenia. Psychiatr Pol. 2015; 49:1149-58. https://doi.org/10.12740/PP/37705 PMid:26909392

Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, et al. A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. Psychiatry Res. 2014; 215:268-73. https://doi.org/10.1016/j.psychres.2013.12.009 PMid:24377440

Rowbotham IM, Orsucci FF, Mansour MF, Chamberlain SR, Raja HY. Relevance of Brain-derived Neurotrophic Factor Levels in Schizophrenia: A Systematic Review and Meta-Analysis. AIMS Neurosci. 2015; 2:280-93. https://doi.org/10.3934/Neuroscience.2015.4.280

Fernandes BS, Steiner J, Berk M, Molendijk ML, Gonzalez-Pinto A, Turck CW, et al. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol Psychiatry. 2015; 20:1108-19. https://doi.org/10.1038/mp.2014.117 PMid:25266124

Pluchino N, Russo M, Santoro AN, Litta P, Cela V, Genazzani AR. Steroid hormones and BDNF. Neuroscience. 2013; 239:271-9. https://doi.org/10.1016/j.neuroscience.2013.01.025 PMid:23380505

Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging. 2005; 26:115-23. https://doi.org/10.1016/j.neurobiolaging.2004.03.002 PMid:15585351

Araya AV, Orellana X, Espinoza J. Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences. Endocrine. 2008; 33:300-4. https://doi.org/10.1007/s12020-008-9090-x PMid:19012000

Effendy E, Loebis B, Amir N, Siregar AY. SNP8NRG433E1006 Neuregulin-1 genetic variation in bataks ethnic with schizophrenia paranoid and healthy control. Bali Med J. 2014; 3. https://doi.org/10.15562/bmj.v3i2.75

Published

2019-07-06

How to Cite

1.
Hendriati D, Effendy E, Amin MM, Camellia V, Husada MS. Brain-Derived Neurotropic Factor Serum Level and Severity Symptom of Bataknese Male Patients with Schizophrenia in North Sumatera, Indonesia. Open Access Maced J Med Sci [Internet]. 2019 Jul. 6 [cited 2024 Apr. 21];7(12):1957-61. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.550

Issue

Section

B - Clinical Sciences

Most read articles by the same author(s)

1 2 3 4 > >>